Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionDividends Paid - CommonDividends Paid - CommonExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares RepurchasedShort-Term Debt issuancesShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Conmed (CNMD) Cash from Investing Activities (2016 - 2026)

Conmed filings provide 17 years of Cash from Investing Activities readings, the most recent being $4.1 million for Q1 2026.

  • On a quarterly basis, Cash from Investing Activities rose 240.25% to $4.1 million in Q1 2026 year-over-year; TTM through Mar 2026 was -$13.9 million, a 0.42% change, with the full-year FY2025 number at -$21.0 million, down 60.17% from a year prior.
  • Cash from Investing Activities hit $4.1 million in Q1 2026 for Conmed, up from -$7.1 million in the prior quarter.
  • In the past five years, Cash from Investing Activities ranged from a high of $4.1 million in Q1 2026 to a low of -$148.3 million in Q2 2022.
  • Median Cash from Investing Activities over the past 5 years was -$4.9 million (2023), compared with a mean of -$17.6 million.
  • Biggest five-year swings in Cash from Investing Activities: tumbled 4852.1% in 2022 and later skyrocketed 240.25% in 2026.
  • Conmed's Cash from Investing Activities stood at -$6.3 million in 2022, then rose by 23.16% to -$4.9 million in 2023, then grew by 16.79% to -$4.0 million in 2024, then crashed by 76.01% to -$7.1 million in 2025, then skyrocketed by 157.77% to $4.1 million in 2026.
  • The last three reported values for Cash from Investing Activities were $4.1 million (Q1 2026), -$7.1 million (Q4 2025), and -$5.2 million (Q3 2025) per Business Quant data.